1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Results 101-120 of 122 (Search time: 0.003 seconds).

Issue DateTitleAuthor(s)
10119-May-2017Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin InteractionsCao, Fan ; Fang, Yiwen ; Tan, Hong Kee ; Goh, Yufen ; Choy, Jocelyn Yeen Hui; Koh, Bryan Thean Howe; Tan, Jiong Hao; Bertin, Nicolas; Ramadass, Aroul; Hunter, Ewan; Green, Jayne; Salter, Matthew; Akoulitchev, Alexandre; Wang, Wilson ; Chng, Wee Joo ; Tenen, Daniel G ; Fullwood, Melissa J 
10225-Jan-2022T and NK cell lymphoma cell lines do not rely on ZAP-70 for survivalde Mel, Sanjay; Mustafa, Nurulhuda; Selvarajan, Viknesvaran; Azaman, Muhammad Irfan; Jaynes, Patrick William ; Venguidessane, Shruthi; Phuong, Hoang Mai; Alnaseri, Zubaida Talal; Phyu, The ; Girard, Louis-Pierre; Chng, Wee Joo ; Wardyn, Joanna; Li, Ying ; An, Omer ; Yang, Henry ; Ng, Siok Bian ; Jeyasekharan, Anand D 
1031-Jan-2021T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor GenesOon, Ming Liang; Lim, Jing Quan ; Lee, Bernett; Leong, Sai Mun ; Soon, Gwyneth Shook-Ting ; Wong, Zi Wei; Lim, Evelyn Huizi ; Li, Zhenhua ; Yeoh, Allen Eng Juh ; Chen, Shangying ; Ban, Kenneth Hon Kim ; Chung, Tae-Hoon ; Tan, Soo-Yong ; Chuang, Shih-Sung; Kato, Seiichi; Nakamura, Shigeo; Takahashi, Emiko; Ho, Yong-Howe; Khoury, Joseph D; Au-Yeung, Rex KH; Cheng, Chee-Leong ; Lim, Soon-Thye ; Chng, Wee-Joo ; Tripodo, Claudio; Rotzschke, Olaf; Ong, Choon Kiat ; Ng, Siok-Bian 
10429-Apr-2020Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationKong, Li Ren ; Ong, Richard Weijie; Tan, Tuan Zea ; Salleh, Nur Afiqah Binte Mohamed ; Thangavelu, Matan; Chan, Jane Vin; Koh, Lie Yong Judice; Periyasamy, Giridharan; Lau, Jieying Amelia ; Le, Thi Bich Uyen; Wang, Lingzhi ; Lee, Miyoung; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Chwee Ming ; Chng, Wee Joo ; Lane, David P ; Venkitaraman, Ashok ; Hung, Huynh The; Cheok, Chit Fang ; Goh, Boon Cher 
10515-Mar-2023Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer ImmunotherapyRan, XB; Ding, LW ; Sun, QY ; Yang, H ; Said, JW; Zhentang, L ; Madan, V ; Dakle, P ; Xiao, JF; Loh, X ; Li, Y ; Xu, L ; Xiang, XQ; Wang, LZ; Goh, BC ; Lin, DC; Chng, WJ ; Tan, SY ; Jha, S ; Koeffler, HP 
1062008The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibitionChng, W.J. ; Braggio, E.; Fonseca, R.; Mulligan, G.; Bryant, B.; Remstein, E.; Dogan, A.; Valdez, R.
1071-Jul-2019The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell LymphomaMing Liang Oon; Michal Hoppe ; Shuangyi Fan ; The Phyu ; Hoang Phuong ; Soo Yong Tan ; Susan Swee-Shan Hue ; Shi Wang ; Li Mei Poon ; Esther Chan ; Joanne Lee; Yen Lin Chee ; Wee Joo Chng ; Sanjay de Mel; Xin Liu; Anand Jeyasekharan ; Siok Bian Ng 
10830-Jun-2022The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens.Blasiak, Agata ; Truong, Anh TL ; Remus, Alexandria ; Hooi, Lissa ; Seah, Shirley Gek Kheng; Wang, Peter ; Chye, De Hoe; Lim, Angeline Pei Chiew; Ng, Kim Tien; Teo, Swee Teng ; Tan, Yee-Joo ; Allen, David Michael ; Chai, Louis Yi Ann ; Chng, Wee Joo ; Lin, Raymond TP; Lye, David CB ; Wong, John Eu-Li ; Tan, Gek-Yen Gladys; Chan, Conrad En Zuo; Chow, Edward Kai-Hua ; Ho, Dean 
9Aug-2012The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study groupTan, D.; Ong, K.H.; Koh, L.P.; Wong, S.S.; Khin, M.T.; Lee, L.H.; Goh, Y.T.; Chng, W.J. 
10Sep-2013The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma networkTan, D.; Kim, K.; Kim, J.S.; Eom, H.-S.; Teoh, G.; Ong, K.H.; Goh, Y.T.; Durie, B.G.M.; Chng, W.J. ; Lee, J.H.
117-May-2021The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2Lee, Kwok Kin ; Rajagopalan, Deepa; Bhatia, Shreshtha Sailesh; Tirado-Magallanes, Roberto; Chng, Wee Joo ; Jha, Sudhakar
122012The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaZhou J.; Cheong L.-L.; Liu S.-C.; Chong P.S.Y.; Mahara S.; Bi C.; Ong K.O.K.; Zeng Q.; Chng W.J. 
132016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K 
142014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
151-Feb-2022THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair InhibitorsShyamsunder, Pavithra ; Sridharan, Shree Pooja; Madan, Vikas ; Dakle, Pushkar ; Zeya, Cao; Kanojia, Deepika ; Chng, Wee-Joo ; Ong, S Tiong ; Koeffler, H Phillip
16Aug-2013Type II EATL (epitheliotropic intestinal T-cell lymphoma): A neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeTan, S.-Y. ; Chuang, S.-S.; Tang, T.; Tan, L.; Ko, Y.-H.; Chuah, K.-L.; Ng, S.-B. ; Chng, W.-J. ; Gatter, K.; Loong, F.; Liu, Y.-H.; Hosking, P.; Cheah, P.-L.; Teh, B.-T. ; Tay, K.; Koh, M.; Lim, S.-T. 
17Jul-2012Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study GroupTse, E.; Gill, H.; Loong, F.; Kim, S.J.; Ng, S.-B. ; Tang, T.; Ko, Y.-H.; Chng, W.-J. ; Lim, S.-T. ; Kim, W.S.; Kwong, Y.-L.
18Jan-2014Unusual case of metachronous EBV-associated B-cell and NK/T-cell lymphoma mimicking polymyositis-diagnostic challenges and pitfallsChan, E.H.L.; Lu, S.-J.; Petersson, F.; Tan, K.-B. ; Chng, W.-J. ; Ng, S.-B. 
192017VS-5584 mediates potent anti-myeloma activity via the upregulation of a class II tumor suppressor gene, RARRES3 and the activation of BimMustafa, N ; Ting Lee, J.X ; Adina Nee, H.F ; Bi, C; Chung, T.-H ; Hart, S; Chng, W.J 
20Feb-2013VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerHart, S.; Novotny-Diermayr, V.; Goh, K.C.; Williams, M.; Tan, Y.C.; Ong, L.C.; Cheong, A.; Ng, B.K.; Amalini, C.; Madan, B.; Nagaraj, H.; Jayaraman, R.; Pasha, K.M.; Ethirajulu, K.; Chng, W.J. ; Mustafa, N.; Goh, B.C. ; Benes, C.; McDermott, U.; Garnett, M.; Dymock, B.; Wood, J.M.